logo
Select company
Select metric
Ticker Information

Ticker

AARD

Company Name

AARDVARK THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

AARDVARK THERAPEUTICS INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AARD - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
12/31/2024$ 51.91M
12/31/2023$ -5.82M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AARDVARK THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ -5.82M.
  • Over the past 5 years, AARDVARK THERAPEUTICS INC's average CF - Chg. Cash has been $ 23.04M.
  • The median CF - Chg. Cash for AARDVARK THERAPEUTICS INC during this period was $ 23.04M
  • AARDVARK THERAPEUTICS INC reached its highest CF - Chg. Cash over the past 5 years at $ 51.91M.
  • The lowest CF - Chg. Cash recorded by AARDVARK THERAPEUTICS INC in the same timeframe $ -5.82M

AARDVARK THERAPEUTICS INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
GALT : GALECTIN THERAPEUTICS INC $ -11.83MJBIO : JADE BIOSCIENCES INC $ 154.24MFENC : FENNEC PHARMACEUTICALS INC $ -24.35MOABI : OMNIAB INC $ -2.51MVNDA : VANDA PHARMACEUTICALS INC $ -21.97MALLO : ALLOGENE THERAPEUTICS INC $ -118.33MLCTX : LINEAGE CELL THERAPEUTICS INC $ 12.61MNMRA : NEUMORA THERAPEUTICS INC $ -27.37MFDMT : 4D MOLECULAR THERAPEUTICS INC $ -111.9MLXEO : LEXEO THERAPEUTICS INC $ -139.5M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

AARD - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -5.82M

Minimum

Dec 31, 2023

$ 51.91M

Maximum

Dec 31, 2024

$ 23.04M

Average

$ 23.04M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.18M
median$ 115.89K
std$ 44.92M